In short. Exosomes are not an approved product class: no injectable exosome product holds a medicine approval, and describing the liquid as a cosmetic ingredient does not change what happens when it is injected. Without a category, there is no required dose, no manufacturing standard, no controlled trials and no system that counts harm.
Key points
- A regulated product belongs to a category, and the category decides what must be demonstrated.
- An injected liquid that changes the skin is acting as a medicine in most frameworks.
- No injectable exosome product holds the approval that a medicine requires.
- Without an approval there is no defined dose, no manufacturing standard and no controlled trials.
- An unapproved product has no batch chain, so a bad batch cannot be traced or recalled.
What does it mean for a product to belong to a category?
A regulated medical product belongs to a category, and the category decides what has to be demonstrated before it can be sold. A medicine has to show in controlled trials that it does something for a stated condition, and it is approved for that condition. A device has to perform to a stated specification for a stated purpose. A cosmetic is regulated by its intended use, and the line it may not cross is claiming to treat a condition or to change the structure or function of the body.
The gap
Products sold as exosomes for injection do not sit cleanly in any of these. A liquid injected into the skin in order to change it is, in most frameworks, acting as a medicine, and a medicine needs an approval that no such product holds. Describing the same liquid as a cosmetic ingredient does not change what happens when it is injected. Where a product is derived from human tissue, a further set of rules usually applies: donor screening, processing standards, and a validated method of reducing the risk of transmitting infection.
Why the sequence does not add up
The commercial answer has been to sit outside every category at once. A product can be manufactured as a cosmetic ingredient, shipped as a laboratory reagent, and injected in a clinic. Each step is defensible in isolation and the sequence is not, because no single regulator sees the whole picture.
What is missing for a person being offered one
Everything an approval would have established is missing. There is no defined dose, because nothing was ever required to specify one. There is no established manufacturing standard, so two batches need not be alike. There are no controlled trials, so nobody can state what the injection does in people beyond the clinic's own account of its own patients. There is no systematic collection of adverse events, so harm is recorded only by whoever chooses to.
| What an approval would establish | What exists without it | What it means in practice | What cannot be done |
|---|---|---|---|
| A defined dose | Nothing required anyone to establish one | The amount injected is whatever the supplier or clinic decided | No basis for saying whether it is too little, enough or too much |
| A manufacturing standard | No standard, so two batches need not be alike | One batch is no guide to the next | No basis for comparing batches |
| Controlled trials | No trials of what the injection does in people | What is known comes from the clinic's account of its own patients | No stated effect for a stated condition |
| Systematic collection of adverse events | Harm recorded only by whoever chooses to report it | A problem may never be recorded | No count of harm across people treated |
| A label, a manufacturer and a batch number | None of that chain | A bad batch cannot be traced back | It cannot be identified, recalled or linked to the people who received it |
An approval is a set of obligations, not a compliment
Approval means that someone specified what the product is, how it is made, what it is for, and what happens when it goes wrong. Its absence is not a judgement about whether the product works. It is the absence of all of those things, and the cost falls on the person receiving the injection.
What can an unapproved injectable not offer?
One consequence is practical. A regulated product carries a label, a manufacturer and a batch number, and that chain is what makes it possible to trace a problem back and to withdraw stock. An unapproved product sold through clinics has none of it, so a bad batch cannot be identified, recalled, or linked to the people who received it.
An unapproved injectable cannot offer a defined dose, because no one was required to establish one. It cannot offer a route to trace or recall a batch if a problem appears later. And it cannot offer a system that counts harm, because nobody is obliged to report it.
Why does the category gap matter?
The category gap is not a technicality. It is the reason the other questions about these products cannot be answered.
Sources
- U.S. Food and Drug Administration: statements on unapproved injectable products marketed as exosomes or birth tissue products
- Medicines and Healthcare products Regulatory Agency (MHRA): guidance on unapproved injectable products
- Therapeutic Goods Administration (TGA): statements on unapproved exosome and birth tissue products
Source links open each organisation's search results for the topic. Document-level confirmation is pending the reviewer's sign-off.
Internal links
Frequently asked questions
Which regulated category would an injectable exosome product belong to?
In most frameworks a liquid injected into the skin in order to change it is acting as a medicine, and a medicine requires an approval for a stated indication that no product of this kind holds. Where the material is of human tissue origin, a separate set of requirements usually applies covering donor screening, processing and reducing the risk of transmission. Neither route has been completed.
Does it matter whether the product is described as a cosmetic or a medicine?
It matters a great deal to the seller and not at all to the substance. A cosmetic is regulated by its intended use and may not claim to treat a condition or to change the structure of the body. Describing a liquid as a cosmetic ingredient does not change what happens when that liquid is injected, and it does not bring an assessment of the injected use with it.
Why does an unapproved product have no dose?
Because nothing required anyone to establish one. A dose is a finding, produced by studies that measure what is given and what follows. Where no such work was required and none was done, the amount injected is whatever the supplier or the clinic decided, and there is no basis for saying whether it is too little, enough, or too much.
Risks & Limitations
- No product marketed as an exosome injectable has been through the approval process that would establish what it contains or what it does.
- Birth tissue derived material carries an infection risk when it is injected, and serious infections have been reported after such injections.
- The evidence behind most claims comes from laboratory work, animal models or uncontrolled case series, none of which establishes an effect in people.
- Regulatory status differs by country, and in most markets there is no approval for these products in any injectable use.
- Nothing on this site is a recommendation for or against any treatment, and it does not assess individual cases.
When to Seek Care
- Spreading redness, heat, swelling or discharge at an injection site: have it assessed promptly.
- Fever, or feeling unwell with a painful injected area: seek medical care without waiting.
- Severe or worsening pain, blistering, or skin breakdown where something was injected.
- Any new and persistent symptom after a treatment: have it assessed by a clinician who can examine you.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.